{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:44:05Z","timestamp":1789015445845,"version":"build-2803163510"},"reference-count":55,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recent data suggest that mast cells (MCs) in patients with systemic mastocytosis or mast cell leukemia express a CD2-reactive antigen. To explore the biochemical nature and function of this antigen, primary MCs as well as the MC line HMC-1 derived from a patient with mast cell leukemia were examined. Northern blot experiments revealed expression of CD2 messenger RNA in HMC-1, whereas primary nonneoplastic MCs did not express transcripts for CD2. In cell surface staining experiments, bone marrow (BM) MCs in systemic mastocytosis (n\u2009=\u200912) as well as HMC-1 cells (30%-80%) were found to express the T11-1 and T11-2 (but not T11-3) epitopes of CD2. By contrast, BM MCs in myelodysplastic syndromes and nonhematologic disorders (bronchiogenic carcinoma, foreskin phimosis, uterine myeomata ) were consistently CD2\u2212. All MC species analyzed including HMC-1 were found to express LFA-3 (CD58), the natural ligand of CD2. To study the functional role of CD2 on neoplastic MCs, CD2+ and CD2\u2212 HMC-1 cells were separated by cell sorting. CD2+ HMC-1 cells were found to form spontaneous aggregates and rosettes with sheep erythrocytes in excess over CD2\u2212cells, and a T11-1 antibody inhibited both the aggregation and rosette formation. Moreover, exposure of CD2+ HMC-1 cells to T11-1 or T11-2 antibody was followed by expression of T11-3. In addition, stimulation of neoplastic MCs through T11-3 and a second CD2 epitope resulted in histamine release. These data show that neoplastic MCs express functionally active CD2. It is hypothesized that expression of CD2 is associated with pathologic accumulation and function of MCs in systemic mastocytosis.<\/jats:p>","DOI":"10.1182\/blood.v98.13.3784","type":"journal-article","created":{"date-parts":[[2002,10,28]],"date-time":"2002-10-28T20:44:12Z","timestamp":1035837852000},"page":"3784-3792","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":39,"title":["Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells"],"prefix":"10.1182","volume":"98","author":[{"given":"Gerit-Holger","family":"Schernthaner","sequence":"first","affiliation":[{"name":"From the Department of Internal Medicine I, Division of Hematology & Hemostaseology, Institute of Immunology, Institute of Pathophysiology, Department of Obstetrics and Gynecology, Division of Gynecological Endocrinology and Reproductive Medicine, University of Vienna, Austria; Axxima Pharmaceuticals, Martinsried, Germany; Servicio de Hematologia, Mast Cell Unit, Hospital Ramo\u0301n y Cajal, University of Alcala\u0301 de Henares, Madrid, Spain; and St Anna Children's Hospital, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-Hendrik","family":"Jordan","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine I, Division of Hematology & Hemostaseology, Institute of Immunology, Institute of Pathophysiology, Department of Obstetrics and Gynecology, Division of Gynecological Endocrinology and Reproductive Medicine, University of Vienna, Austria; Axxima Pharmaceuticals, Martinsried, Germany; Servicio de Hematologia, Mast Cell Unit, Hospital Ramo\u0301n y Cajal, University of Alcala\u0301 de Henares, Madrid, Spain; and St Anna Children's Hospital, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoo","family":"Ghannadan","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine I, Division of Hematology & Hemostaseology, Institute of Immunology, Institute of Pathophysiology, Department of Obstetrics and Gynecology, Division of Gynecological Endocrinology and Reproductive Medicine, University of Vienna, Austria; Axxima Pharmaceuticals, Martinsried, Germany; Servicio de Hematologia, Mast Cell Unit, Hospital Ramo\u0301n y Cajal, University of Alcala\u0301 de Henares, Madrid, Spain; and St Anna Children's Hospital, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermine","family":"Agis","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine I, Division of Hematology & Hemostaseology, Institute of Immunology, Institute of Pathophysiology, Department of Obstetrics and Gynecology, Division of Gynecological Endocrinology and Reproductive Medicine, University of Vienna, Austria; Axxima Pharmaceuticals, Martinsried, Germany; Servicio de Hematologia, Mast Cell Unit, Hospital Ramo\u0301n y Cajal, University of Alcala\u0301 de Henares, Madrid, Spain; and St Anna Children's Hospital, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorian","family":"Bevec","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine I, Division of Hematology & Hemostaseology, Institute of Immunology, Institute of Pathophysiology, Department of Obstetrics and Gynecology, Division of Gynecological Endocrinology and Reproductive Medicine, University of Vienna, Austria; Axxima Pharmaceuticals, Martinsried, Germany; Servicio de Hematologia, Mast Cell Unit, Hospital Ramo\u0301n y Cajal, University of Alcala\u0301 de Henares, Madrid, Spain; and St Anna Children's Hospital, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Nun\u0303ez","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine I, Division of Hematology & Hemostaseology, Institute of Immunology, Institute of Pathophysiology, Department of Obstetrics and Gynecology, Division of Gynecological Endocrinology and Reproductive Medicine, University of Vienna, Austria; Axxima Pharmaceuticals, Martinsried, Germany; Servicio de Hematologia, Mast Cell Unit, Hospital Ramo\u0301n y Cajal, University of Alcala\u0301 de Henares, Madrid, Spain; and St Anna Children's Hospital, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Escribano","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine I, Division of Hematology & Hemostaseology, Institute of Immunology, Institute of Pathophysiology, Department of Obstetrics and Gynecology, Division of Gynecological Endocrinology and Reproductive Medicine, University of Vienna, Austria; Axxima Pharmaceuticals, Martinsried, Germany; Servicio de Hematologia, Mast Cell Unit, Hospital Ramo\u0301n y Cajal, University of Alcala\u0301 de Henares, Madrid, Spain; and St Anna Children's Hospital, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Majdic","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine I, Division of Hematology & Hemostaseology, Institute of Immunology, Institute of Pathophysiology, Department of Obstetrics and Gynecology, Division of Gynecological Endocrinology and Reproductive Medicine, University of Vienna, Austria; Axxima Pharmaceuticals, Martinsried, Germany; Servicio de Hematologia, Mast Cell Unit, Hospital Ramo\u0301n y Cajal, University of Alcala\u0301 de Henares, Madrid, Spain; and St Anna Children's Hospital, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Willheim","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine I, Division of Hematology & Hemostaseology, Institute of Immunology, Institute of Pathophysiology, Department of Obstetrics and Gynecology, Division of Gynecological Endocrinology and Reproductive Medicine, University of Vienna, Austria; Axxima Pharmaceuticals, Martinsried, Germany; Servicio de Hematologia, Mast Cell Unit, Hospital Ramo\u0301n y Cajal, University of Alcala\u0301 de Henares, Madrid, Spain; and St Anna Children's Hospital, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Worda","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine I, Division of Hematology & Hemostaseology, Institute of Immunology, Institute of Pathophysiology, Department of Obstetrics and Gynecology, Division of Gynecological Endocrinology and Reproductive Medicine, University of Vienna, Austria; Axxima Pharmaceuticals, Martinsried, Germany; Servicio de Hematologia, Mast Cell Unit, Hospital Ramo\u0301n y Cajal, University of Alcala\u0301 de Henares, Madrid, Spain; and St Anna Children's Hospital, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Printz","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine I, Division of Hematology & Hemostaseology, Institute of Immunology, Institute of Pathophysiology, Department of Obstetrics and Gynecology, Division of Gynecological Endocrinology and Reproductive Medicine, University of Vienna, Austria; Axxima Pharmaceuticals, Martinsried, Germany; Servicio de Hematologia, Mast Cell Unit, Hospital Ramo\u0301n y Cajal, University of Alcala\u0301 de Henares, Madrid, Spain; and St Anna Children's Hospital, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Fritsch","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine I, Division of Hematology & Hemostaseology, Institute of Immunology, Institute of Pathophysiology, Department of Obstetrics and Gynecology, Division of Gynecological Endocrinology and Reproductive Medicine, University of Vienna, Austria; Axxima Pharmaceuticals, Martinsried, Germany; Servicio de Hematologia, Mast Cell Unit, Hospital Ramo\u0301n y Cajal, University of Alcala\u0301 de Henares, Madrid, Spain; and St Anna Children's Hospital, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Lechner","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine I, Division of Hematology & Hemostaseology, Institute of Immunology, Institute of Pathophysiology, Department of Obstetrics and Gynecology, Division of Gynecological Endocrinology and Reproductive Medicine, University of Vienna, Austria; Axxima Pharmaceuticals, Martinsried, Germany; Servicio de Hematologia, Mast Cell Unit, Hospital Ramo\u0301n y Cajal, University of Alcala\u0301 de Henares, Madrid, Spain; and St Anna Children's Hospital, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valent","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine I, Division of Hematology & Hemostaseology, Institute of Immunology, Institute of Pathophysiology, Department of Obstetrics and Gynecology, Division of Gynecological Endocrinology and Reproductive Medicine, University of Vienna, Austria; Axxima Pharmaceuticals, Martinsried, Germany; Servicio de Hematologia, Mast Cell Unit, Hospital Ramo\u0301n y Cajal, University of Alcala\u0301 de Henares, Madrid, Spain; and St Anna Children's Hospital, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021217340876600_B1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2559.1979.tb03017.x","article-title":"Mast cells and mast cell neoplasia: a review.","volume":"3","author":"Lennert","year":"1979","journal-title":"Histopathology."},{"key":"2020021217340876600_B2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0344-0338(85)80184-9","article-title":"Tissue mast cells in health and disease.","volume":"179","author":"Parwaresch","year":"1985","journal-title":"Pathol Res Pract."},{"key":"2020021217340876600_B3","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1111\/1523-1747.ep12468882","article-title":"Classification and diagnosis of mastocytosis: current status.","volume":"96","author":"Metcalfe","year":"1991","journal-title":"J Invest Dermatol."},{"key":"2020021217340876600_B4","first-page":"385","article-title":"Biology, classification and treatment of human mastocytosis.","volume":"108","author":"Valent","year":"1996","journal-title":"Wien Klin Wochenschr."},{"key":"2020021217340876600_B5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal.","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res."},{"key":"2020021217340876600_B6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00005792-198811000-00001","article-title":"Systemic mast cell disease: analysis of 58 cases and literature review.","volume":"67","author":"Travis","year":"1988","journal-title":"Medicine."},{"key":"2020021217340876600_B7","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1111\/1523-1747.ep12468899","article-title":"Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital.","volume":"96","author":"Horan","year":"1991","journal-title":"J Invest Dermatol."},{"key":"2020021217340876600_B8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archderm.1963.01590140008002","article-title":"The natural course of urticaria pigmentosa.","volume":"87","author":"Caplan","year":"1963","journal-title":"Arch Dermatol."},{"key":"2020021217340876600_B9","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0046-8177(85)80252-5","article-title":"Bone marrow findings in systemic mastocytosis.","volume":"16","author":"Horny","year":"1985","journal-title":"Hum Pathol."},{"key":"2020021217340876600_B10","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0025-6196(12)62636-6","article-title":"Mast cell leukemia: report of a case and review of literature.","volume":"61","author":"Travis","year":"1986","journal-title":"Mayo Clin Proc."},{"key":"2020021217340876600_B11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2141.1986.tb04133.x","article-title":"Mast cell leukemia: evidence for bone marrow origin of the pathological clone.","volume":"64","author":"Dalton","year":"1986","journal-title":"Br J Haematol."},{"key":"2020021217340876600_B12","first-page":"159","article-title":"A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotype characterization of the malignant clone.","volume":"10","author":"Baghestanian","year":"1996","journal-title":"Leukemia."},{"key":"2020021217340876600_B13","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","article-title":"Identification of mutations in the coding sequence of the protooncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of the c-kit product.","volume":"92","author":"Furitsu","year":"1993","journal-title":"J Clin Invest."},{"key":"2020021217340876600_B14","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood.V88.3.995.995","article-title":"Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase.","volume":"88","author":"Kitayama","year":"1996","journal-title":"Blood."},{"key":"2020021217340876600_B15","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021217340876600_B16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng0396-312","article-title":"Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.","volume":"12","author":"Longley","year":"1996","journal-title":"Nat Gen."},{"key":"2020021217340876600_B17","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-kit catalytic domain mutations in distinct forms of human mastocytosis.","volume":"96","author":"Longley","year":"1999","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021217340876600_B18","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2362.1995.tb01948.x","article-title":"Mast cell differentiation antigens: expression in normal and malignant cells and use for diagnostic purposes.","volume":"25","author":"Valent","year":"1995","journal-title":"Eur J Clin Invest."},{"key":"2020021217340876600_B19","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0091-6749(96)70133-1","article-title":"The presence of membrane-bound stem cell factor on highly immature nonmetachromatic mast cells in the peripheral blood of a patient with aggressive systemic mastocytosis.","volume":"98","author":"Castells","year":"1996","journal-title":"J Allergy Clin Immunol."},{"key":"2020021217340876600_B20","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1365-2141.1995.tb05417.x","article-title":"Expression of lymphoid-associated antigens in mast cells: report of a case of systemic mast cell disease.","volume":"91","author":"Escribano","year":"1995","journal-title":"Br J Haematol."},{"key":"2020021217340876600_B21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1097-0320(19970415)30:2<98::AID-CYTO4>3.0.CO;2-9","article-title":"Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia.","volume":"30","author":"Escribano","year":"1997","journal-title":"Cytometry."},{"key":"2020021217340876600_B22","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood.V91.8.2731.2731_2731_2736","article-title":"Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications.","volume":"91","author":"Escribano","year":"1998","journal-title":"Blood."},{"key":"2020021217340876600_B23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1155\/1998\/341340","article-title":"Immunophenotypic characterization of human bone marrow mast cells: a flow cytometric study of normal and pathologic bone marrow samples.","volume":"16","author":"Escribano","year":"1998","journal-title":"Anal Cell Pathol."},{"key":"2020021217340876600_B24","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0092-8674(84)90039-4","article-title":"An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein.","volume":"36","author":"Meuer","year":"1984","journal-title":"Cell."},{"key":"2020021217340876600_B25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4049\/jimmunol.131.2.611","article-title":"The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions.","volume":"131","author":"Krensky","year":"1983","journal-title":"J Immunol."},{"key":"2020021217340876600_B26","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/326400a0","article-title":"The T lymphocyte glycoprotein CD2 binds cell surface ligand LFA-3.","volume":"326","author":"Selvaraj","year":"1987","journal-title":"Nature."},{"key":"2020021217340876600_B27","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/329842a0","article-title":"Monoclonal antibody and ligand binding sites of the T cell erythrocyte receptor (CD2).","volume":"329","author":"Peterson","year":"1987","journal-title":"Nature."},{"key":"2020021217340876600_B28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/03009748809102963","article-title":"Structure and function of the erythrocyte receptor CD2 on human T lymphocytes: a review.","volume":"76","author":"Sayre","year":"1988","journal-title":"Scand J Rheumatol."},{"key":"2020021217340876600_B29","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1146\/annurev.iy.07.040189.003051","article-title":"The biologic roles of CD2, CD4, and CD8 in T-cell activation.","volume":"7","author":"Bierer","year":"1989","journal-title":"Ann Rev Immunol."},{"key":"2020021217340876600_B30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-065X.1989.tb00544.x","article-title":"The structural biology of CD2.","volume":"111","author":"Moingeon","year":"1989","journal-title":"Immunol Rev."},{"key":"2020021217340876600_B31","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.4049\/jimmunol.155.6.2805","article-title":"CD2 and the regulation of T-cell anergy.","volume":"155","author":"Bell","year":"1995","journal-title":"J Immunol."},{"key":"2020021217340876600_B32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-065X.1996.tb00922.x","article-title":"The role of CD2 as a regulator of human T-cell cytokine production.","volume":"153","author":"Holter","year":"1996","journal-title":"Immunol Rev."},{"key":"2020021217340876600_B33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes.","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol."},{"key":"2020021217340876600_B34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0022-1759(95)00034-8","article-title":"Purification of human basophils and mast cells by multistep separation technique and mAb to CDw17 and CD117\/C-kit.","volume":"182","author":"Willheim","year":"1995","journal-title":"J Immunol Methods."},{"key":"2020021217340876600_B35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0145-2126(88)90050-1","article-title":"Establishment of an immature mast cell line from a patient with mast cell leukemia.","volume":"12","author":"Butterfield","year":"1988","journal-title":"Leuk Res."},{"key":"2020021217340876600_B36","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/stem.5530130510","article-title":"Comparison of purity and enrichment of CD34+ from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems.","volume":"13","author":"De Wynter","year":"1995","journal-title":"Stem Cells."},{"key":"2020021217340876600_B37","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood.V80.9.2237.2237","article-title":"Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor\/kit-ligand in long-term culture.","volume":"80","author":"Valent","year":"1992","journal-title":"Blood."},{"key":"2020021217340876600_B38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4049\/jimmunol.157.1.343","article-title":"Selective growth of human mast cells induced by steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells.","volume":"157","author":"Saito","year":"1996","journal-title":"J Immunol."},{"key":"2020021217340876600_B39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1084\/jem.190.2.267","article-title":"T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro.","volume":"190","author":"Ochi","year":"1999","journal-title":"J Exp Med."},{"key":"2020021217340876600_B40","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1034\/j.1399-0039.1999.540507.x","article-title":"Expression of homing receptors and related molecules on human mast cells and basophils: a comparative analysis using multi-color flow cytometry and toluidine blue\/immunofluorescence staining technique.","volume":"54","author":"Wimazal","year":"1999","journal-title":"Tissue Antigens."},{"key":"2020021217340876600_B41","first-page":"1493","article-title":"Flow cytometric identification and enumeration of mast cells from both normal and pathological human bone marrow samples.","volume":"149","author":"Orfao","year":"1996","journal-title":"Am J Pathol."},{"key":"2020021217340876600_B42","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1182\/blood.V73.7.1778.1778","article-title":"Mast cell typing: demonstration of a distinct hemopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes.","volume":"73","author":"Valent","year":"1989","journal-title":"Blood."},{"key":"2020021217340876600_B43","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1046\/j.1523-1747.1998.00359.x","article-title":"Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies.","volume":"111","author":"Ghannadan","year":"1998","journal-title":"J Invest Dermatol."},{"key":"2020021217340876600_B44","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/29.4.6166661","article-title":"Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.","volume":"29","author":"Hsu","year":"1981","journal-title":"J Histochem Cytochem."},{"key":"2020021217340876600_B45","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1073\/pnas.83.12.4464","article-title":"Two types of human mast cells that chave distinct neutral protease compositions.","volume":"83","author":"Irani","year":"1986","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021217340876600_B46","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/00000478-199809000-00013","article-title":"Diagnostic value of immunostaining for tryptase in patients with mastocytosis.","volume":"22","author":"Horny","year":"1998","journal-title":"Am J Surg Pathol."},{"key":"2020021217340876600_B47","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1021\/bi00591a005","article-title":"Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.","volume":"18","author":"Chirgwin","year":"1979","journal-title":"Biochemistry."},{"key":"2020021217340876600_B48","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1073\/pnas.88.8.3339","article-title":"Interleukin 4 promotes expression of mast cell ICAM-1 antigen.","volume":"88","author":"Valent","year":"1991","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021217340876600_B49","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1182\/blood.V90.11.4438","article-title":"The c-kit ligand stem cell factor and anti-IgE promote expression of monocyte chemoattractant protein 1 (MCP-1) in human lung mast cells.","volume":"90","author":"Baghestanian","year":"1997","journal-title":"Blood."},{"key":"2020021217340876600_B50","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1073\/pnas.84.9.2941","article-title":"Molecular cloning and expression of T11 cDNAs reveal a receptor-like structure on human T lymphocytes.","volume":"84","author":"Sayre","year":"1987","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021217340876600_B51","doi-asserted-by":"crossref","first-page":"15335","DOI":"10.1016\/S0021-9258(19)37593-3","article-title":"Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene.","volume":"263","author":"Ercolani","year":"1988","journal-title":"J Biol Chem."},{"key":"2020021217340876600_B52","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1073\/pnas.86.14.5542","article-title":"Interleukin-3 activates human blood basophils via high affinity binding sites.","volume":"86","author":"Valent","year":"1989","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021217340876600_B53","first-page":"1377","article-title":"Stem cell factor-induced downregulation of c-kit in human lung mast cells and HMC-1 mast cells.","volume":"24","author":"Baghestanian","year":"1996","journal-title":"Exp Hematol."},{"key":"2020021217340876600_B54","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0065-2776(08)60879-2","article-title":"Cell surface structures on human basophils and mast cells: biochemical and functional characterization.","volume":"52","author":"Valent","year":"1992","journal-title":"Adv Immunol."},{"key":"2020021217340876600_B55","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.173.4.859","article-title":"T cell receptor-independent CD2 signal transduction in FcR+ cells.","volume":"173","author":"Arulanandam","year":"1991","journal-title":"J Exp Med."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/98\/13\/3784\/1678961\/h8240103784.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/98\/13\/3784\/1678961\/h8240103784.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T20:10:43Z","timestamp":1682280643000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/98\/13\/3784\/90231\/Expression-epitope-analysis-and-functional-role-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12,15]]},"references-count":55,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2001,12,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v98.13.3784","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12,15]]}}}